ArticleCommunications biology2026
Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia.
Ge Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.